General Information of the Protein
Protein ID
PT01160
Protein Name
Kinesin-like protein KIF11
Secondarily
Protein Name
Kinesin-like protein 1
Kinesin-like spindle protein HKSP
Kinesin-related motor protein Eg5
Thyroid receptor-interacting protein 5
Gene Name
KIF11
Secondarily
Gene Name
EG5
KNSL1
TRIP5
Sequence
MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQKLTKKALIKEYTEEIERLKRDLAAAREKNGVYISEENFRVMSGKLTVQEEQIVELIEKIGAVEEELNRVTELFMDNKNELDQCKSDLQNKTQELETTQKHLQETKLQLVKEEYITSALESTEEKLHDAASKLLNTVEETTKDVSGLHSKLDRKKAVDQHNAEAQDIFGKNLNSLFNNMEELIKDGSSKQKAMLEVHKTLFGNLLSSSVSALDTITTVALGSLTSIPENVSTHVSQIFNMILKEQSLAAESKTVLQELINVLKTDLLSSLEMILSPTVVSILKINSQLKHIFKTSLTVADKIEDQKKELDGFLSILCNNLHELQENTICSLVESQKQCGNLTEDLKTIKQTHSQELCKLMNLWTERFCALEEKCENIQKPLSSVQENIQQKSKDIVNKMTFHSQKFCADSDGFSQELRNFNQEGTKLVEESVKHSDKLNGNLEKISQETEQRCESLNTRTVYFSEQWVSSLNEREQELHNLLEVVSQCCEASSSDITEKSDGRKAAHEKQHNIFLDQMTIDEDKLIAQNLELNETIKIGLTKLNCFLEQDLKLDIPTGTTPQRKSYLYPSTLVRTEPREHLLDQLKRKQPELLMMLNCSENNKEETIPDVDVEEAVLGQYTEEPLSQEPSVDAGVDCSSIGGVPFFQHKKSHGKDKENRGINTLERSKVEETTEHLVTKSRLPLRAQINL
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Other cytosolic protein
Function
Motor protein required for establishing a bipolar spindle and thus contributing to chromosome congression during mitosis (PubMed:19001501, PubMed:37728657). Required in non-mitotic cells for transport of secretory proteins from the Golgi complex to the cell surface (PubMed:23857769).
    Show/Hide
Uniprot ID
Primary ID:
P52732

Secondarily ID:
A0AV49
B2RMV3
Q15716
Q5VWX0
    Show/Hide
Ensembl ID
ENSG00000138160
HGNC ID
HGNC:6388
Subcellular Location
Cytoplasm
Cytoplasm
Cytoskeleton
Spindle pole
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000068 , A-549
Compound ID Compound Name Compound Formula
CP0427180
3-N,3-N-diethyl-5-methyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C19H24N2O2S2
 1
1
EC50 = 100 nM
   TI
   LI
   LO
   TS
CP0442403
3-N,3-N-diethyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C18H22N2O2S2
 1
1
EC50 = 480 nM
   TI
   LI
   LO
   TS
CP0440383
N-[3-(piperidin-1-ylcarbonyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]thiophene-2-carboxamide
   Show/Hide
C19H22N2O2S2
 1
1
EC50 = 540 nM
   TI
   LI
   LO
   TS
CP0440384
N-[3-(pyrrolidin-1-ylcarbonyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]thiophene-2-carboxamide
   Show/Hide
C18H20N2O2S2
 1
1
EC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0522578
N-[3-(diethylcarbamoyl)-5-methyl-4H,5H,6H-cyclopenta[b]thiophen-2-yl]thiophene-2-carboxamide
   Show/Hide
C18H22N2O2S2
 1
1
EC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0268586
3-N,3-N-diethyl-5,5-dimethyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C20H26N2O2S2
 1
1
EC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0528612
N-[3-(morpholin-4-ylcarbonyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]thiophene-2-carboxamide
   Show/Hide
C18H20N2O3S2
 1
1
EC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0528611
3-N,3-N,5-triethyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C20H26N2O2S2
 1
1
EC50 = 1900 nM
   TI
   LI
   LO
   TS
CP0535460
N-[3-(diethylcarbamoyl)-4H,5H,6H-cyclopenta[b]thiophen-2-yl]thiophene-2-carboxamide
   Show/Hide
C17H20N2O2S2
 1
1
EC50 = 2200 nM
   TI
   LI
   LO
   TS
CP0525776
3-N,3-N-diethyl-6-methyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C19H24N2O2S2
 1
1
EC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0437384
3-N,3-N-dimethyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C16H18N2O2S2
 1
1
EC50 = 3600 nM
   TI
   LI
   LO
   TS
CP0437097
3-N,3-N-diethyl-2-N-(thiophene-3-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C18H22N2O2S2
 1
1
EC50 = 4300 nM
   TI
   LI
   LO
   TS
CP0501506
3-N,3-N-diethyl-4-methyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C19H24N2O2S2
 1
1
EC50 = 4700 nM
   TI
   LI
   LO
   TS
CP0437383
N-[3-(diethylcarbamoyl)-4-methyl-4H,5H,6H-cyclopenta[b]thiophen-2-yl]thiophene-2-carboxamide
   Show/Hide
C18H22N2O2S2
 1
1
EC50 = 5400 nM
   TI
   LI
   LO
   TS
CP0444406
N-[3-(diethylcarbamoyl)-4H,5H,6H,7H,8H-cyclohepta[b]thiophen-2-yl]thiophene-2-carboxamide
   Show/Hide
C19H24N2O2S2
 1
1
EC50 = 5800 nM
   TI
   LI
   LO
   TS
CP0444405
3-N-[2-(dimethylamino)ethyl]-3-N-methyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C19H25N3O2S2
 1
1
EC50 = 7600 nM
   TI
   LI
   LO
   TS
CP0442401
N-[3-(diethylcarbamoyl)-4H,5H,7H-thieno[2,3-c]thiopyran-2-yl]thiophene-2-carboxamide
   Show/Hide
C17H20N2O2S3
 1
1
EC50 = 9600 nM
   TI
   LI
   LO
   TS
CP0435879
3-N,3-N-diethyl-6,6-dimethyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C20H26N2O2S2
 1
1
EC50 = 14000 nM
   TI
   LI
   LO
   TS
CP0432867
3-N,3-N-diethyl-2-N-(thiophene-2-)-4H,5H,7H-thieno[2,3-c]pyran-2,3-diamido
   Show/Hide
C17H20N2O3S2
 1
1
EC50 = 17000 nM
   TI
   LI
   LO
   TS
CP0528613
N-[3-(diethylcarbamoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]furan-2-carboxamide
   Show/Hide
C18H22N2O3S
 1
1
EC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0541768
3-N,3-N-diethyl-4,5-dimethyl-2-N-(thiophene-2-)thiophene-2,3-diamido
   Show/Hide
C16H20N2O2S2
 1
1
EC50 = 29000 nM
   TI
   LI
   LO
   TS
CP0501510
N-[3-(diethylcarbamoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-4-methyl-1,3-thiazole-5-carboxamide
   Show/Hide
C18H23N3O2S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0503101
N-[3-(diethylcarbamoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-1,3-thiazole-5-carboxamide
   Show/Hide
C17H21N3O2S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0525775
3-N,3-N,6-triethyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C20H26N2O2S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0949891
N,N-diethyl-2-(thiophen-2-ylmethylamino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide
   Show/Hide
C18H24N2OS2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0541766
2-N-benzene-3-N,3-N-diethyl-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C20H24N2O2S
 1
1
EC50 = 34000 nM
   TI
   LI
   LO
   TS
CP0501507
3-N-[2-(dimethylamino)ethyl]-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C18H23N3O2S2
 1
1
EC50 = 37000 nM
   TI
   LI
   LO
   TS
CP0047482
2-(thiophene-2-amido)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid
   Show/Hide
C14H13NO3S2
 1
1
EC50 < 30000 nM
   TI
   LI
   LO
   TS
CP0233491
ethyl 2-(thiophene-2-amido)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
   Show/Hide
C16H17NO3S2
 1
1
EC50 < 30000 nM
   TI
   LI
   LO
   TS
CP0433960
3-N,3-N-diethyl-2-N-(thiophene-2-)thiophene-2,3-diamido
   Show/Hide
C14H16N2O2S2
 1
1
EC50 < 30000 nM
   TI
   LI
   LO
   TS
CP0501509
2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C14H14N2O2S2
 1
1
EC50 < 30000 nM
   TI
   LI
   LO
   TS
CP0525774
3-N,3-N-diethyl-2-N-(thiophene-2-)-4H,5H,6H,7H-thieno[2,3-c]pyridine-2,3-diamido
   Show/Hide
C17H21N3O2S2
 1
1
EC50 < 30000 nM
   TI
   LI
   LO
   TS
CP0539692
3-N,3-N-diethyl-2-N-(thiophene-2-)-1-benzothiophene-2,3-diamido
   Show/Hide
C18H18N2O2S2
 1
1
EC50 < 30000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0252482
(S)-2-(3-aminopropyl)-4-(2,5-difluorophenyl)-N,N-dimethyl-2-phenyl-2H-pyrrole-1(5H)-carboxamide
   Show/Hide
C22H25F2N3O
 1
1 IC50 = 2.2 nM
CP0157181
(S)-2-((S)-3-amino-4,4-difluorobutyl)-4-(2,5-difluorophenyl)-N,N-dimethyl-2-phenyl-2H-pyrrole-1(5H)-carboxamide
   Show/Hide
C23H25F4N3O
 1
1 IC50 = 5.2 nM
CP0224339
ARRY-520
   Show/Hide
C20H22F2N4O2S
 2
1 IC50 = 6 nM
2 IC50 = 18 nM
CP0039077
(2R)-2-amino-3-{[(4-methoxyphenyl)diphenylmethyl]sulfanyl}propanoic acid
   Show/Hide
C23H23NO3S
 5
1 IC50 = 28.5 nM
2 IC50 = 166 nM
3 IC50 = 270 nM
4 Ki < 50 nM
5 Ki = 200 nM
CP0063755
6-[4-(Trifluoromethyl)phenyl]-3,4-dihydro-2(1H)-quinolinone
   Show/Hide
C16H12F3NO
 2
1 IC50 = 46 nM
2 Ki = 1.8 nM
CP0148456
(2R)-2-amino-3-[(4-methoxyphenyl)-diphenylmethyl]sulfanylpropan-1-ol
   Show/Hide
C23H25NO2S
 1
1 IC50 = 127 nM
CP0219859
(2S)-2-amino-3-[(4-methoxyphenyl)-diphenylmethyl]sulfanylpropan-1-ol
   Show/Hide
C23H25NO2S
 1
1 IC50 = 130 nM
CP0086475
2-[(4-methoxyphenyl)-diphenylmethyl]sulfanylethanamine
   Show/Hide
C22H23NOS
 1
1 IC50 = 136 nM
CP0082019
(2R)-2-amino-3-[(triphenylmethyl)sulfanyl]propanoic acid
   Show/Hide
C22H21NO2S
 9
1 IC50 = 140 nM
2 IC50 = 185.9 nM
3 IC50 = 284.9 nM
4 IC50 = 620 nM
5 IC50 = 1000 nM
6 IC50 = 1900 nM
7 Ki = 26 nM
8 Ki = 50 nM
9 Ki = 71.9 nM
CP0086558
(2S)-2-amino-3-[(4-methoxyphenyl)-diphenylmethyl]sulfanylpropanoic acid
   Show/Hide
C23H23NO3S
 1
1 IC50 = 230 nM
CP0086460
(2R)-2-amino-3-tritylsulfanylpropan-1-ol
   Show/Hide
C22H23NOS
 1
1 IC50 = 310 nM
CP0068771
N-(4-acetyl-5-methyl-5-phenyl-1,3,4-thiadiazol-2-yl)acetamide
   Show/Hide
C13H15N3O2S
 2
1 IC50 = 800 nM
2 IC50 = 1300 nM
CP0268586
3-N,3-N-diethyl-5,5-dimethyl-2-N-(thiophene-2-)-4,5,6,7-tetrahydro-1-benzothiophene-2,3-diamido
   Show/Hide
C20H26N2O2S2
 1
1 IC50 = 3100 nM
CP0002988
Ethyl 4-(3-hydroxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (11)
   Show/Hide
C14H16N2O3S
 3
1 IC50 = 14000 nM
2 IC50 = 20000 nM
3 IC50 = 30000 nM
Clinical Information about the Protein
Target 1 ( Kinesin-like protein KIF11 (KIF11) )
Target Type Clinical trial Target
Disease 2 Target-related Diseases  2
1 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
2 Acute myeloid leukaemia [ICD-11: 2A60]
Clinical Trial Drug(s) 5 Clinical Trial Drugs  5
1 ARRY-520 Phase 2
Solid tumour/cancer
2 AZD-4877 Phase 2
Acute myeloid leukaemia
3 Ispinesib Phase 2
Solid tumour/cancer
4 LY2523355 Phase 2
Acute myeloid leukaemia
5 MK-0731 Phase 1
Solid tumour/cancer
Target 2 ( Kinesin spindle messenger RNA (KIF11 mRNA) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Haematological malignancy [ICD-11: 2B33.Y]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 EMD-534085 Phase 1
Haematological malignancy